ENOB +39% on HIV/HBV presentations at ASGCT* conference: https://finance.yahoo.com/news/enochian-biosciences-announces-three-scientific-120010637.html ENOB, an 8-person outfit in Los Angeles, went public in Feb 2018 via a reverse merger with DDRT (https://www.prnewswire.com/news-releases/dandrit-biotech-announces-completion-of-the-acquisition-of-enochian-300600864.html ). *American Society of Gene and Cell Therapy.